Changes in BAFF/April levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy

Journal of Investigational Allergology and Clinical Immunology

Volumn 23, Issue 1, 2013, Pages 52-53

  Yoshida, S ^a   Sakurai, Y ^b   Takeda, T ^a   Fukuda, K ^a  

^a NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b Nara Prefectural Mimuro Hospital   (Japan)

Author keywords

April; BAFF; IgA; Intravenous immunoglobulin; Kawasaki disease

Indexed keywords

ANTIBIOTIC AGENT; ASPARTIC ACID; AZITHROMYCIN; CD40 LIGAND; COTRIMOXAZOLE; GLYCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AMINO ACID SUBSTITUTION; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPHYXIA; BLOOD CELL COUNT; CASE REPORT; CHILD; CODON; DIARRHEA; EOSINOPHILIA; EXON; FAILURE TO THRIVE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPER IGM SYNDROME; LEUKOCYTOSIS; LUNG AUSCULTATION; LUNG INFILTRATE; MALE; MISSENSE MUTATION; NEUTROPENIA; NUCHAL CORD; OTITIS MEDIA; PHENOTYPE; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SCREENING TEST; THORAX RADIOGRAPHY;

B-CELL ACTIVATING FACTOR; BLOOD COAGULATION; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTE COUNT; MUCOCUTANEOUS LYMPH NODE SYNDROME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84874380631     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Doi M, Takeda T, Sakurai Y, Kato J, Hayashi T, Fukuda K, Takase T, Shima M. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease. J Investig Allergol Clin Immunol. 2010;20:413-8.
2. Suzuki H, Muragaki Y, Uemura S, Takeuchi T, Minami T, Shibuta S, Ohshima A, Yoshikawa N. Detection of auto-antibodies against a 70 kDa protein derived from vascular smooth muscle cells in patients with Kawasaki disease. Eur J Pediatr. 2002;161:324-9.
3. Janda A, Rensing-Ehl A, Eibel H, Ehl S, Speckmann C. Elevated serum BAFF levels in patients with autoimmunity and lymphoproliferation. Scand J Immunol. 2011;74:518-9.
4. Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur J Immunol. 2007;37:110-8.
5. Rowley AH, Shulman ST. Recent advances in the understanding and management of Kawasaki disease. Curr Infect Dis Rep. 2010;12:96-102.
6. Tezuka H, Abe Y, Asano J, Sato T, Liu J, Iwata M, Ohteki T. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity 2011;34:247-57
7. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA. 2004;101:3903-8.
8. Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Bohm J, Kienzler AK, Pan-Hammarstrom Q, Hammarstrom L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA. 2009;106:13945-50.
9. Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM. BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 2005;115:3083-92.
10. Xiao Y, Motomura S, Deyev V, Podack ER. TNF superfamily member 13, APRIL, inhibits allergic lung inflammation. Eur J Immunol. 2011;41:164-71.